GBP5 as a potential marker for changing trends in transaminase levels in children with infectious mononucleosis: an exploratory study.

OBJECTIVE: This study aims to explore whether GBP5 is associated with changing trends in transaminase levels in children with infectious mononucleosis (IM). METHODS: 100 children with IM were divided into the non-liver injury group (NLIG) and the liver injury group (LIG) according to liver function status. The expression level of GBP5 in peripheral blood mononuclear cells (PBMCs) from each group was measured using qPCR. All children with IM underwent liver function reexamination on day 14 after disease onset, leading to a further division into two groups based on these results: the non-progressive transaminase elevation group (NPTEG) and the progressive transaminase elevation group (PTEG). Clinical data and laboratory examination results from all enrolled children were collected for subsequent analysis. RESULTS: Compared with the NLIG, children in the LIG exhibited a higher GBP5 expression level (p < 0.05). Upon reexamination of liver function on day 14 of disease onset, some children showed progressive increases in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared to those at admission. In the PTEG, the expression levels of GBP5 were elevated (p < 0.05). ROC analysis suggested that GBP5 expression showed apparent discriminatory capacity for identifying the risk of progressive transaminase elevation in children with IM. The time to transaminase recovery below 2 × upper limit of normal (ULN) varied among children with IM-related liver injury. >50% achieved recovery within 30 days, with a maximum recovery time of 130 days. CONCLUSION: GBP5 demonstrated apparent predictive discrimination for changing trends in transaminase levels in children with IM, warranting further multivariable assessment and external validation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-17
DOI
https://doi.org/10.1016/j.jped.2026.101644
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GBP5 as a potential marker for changing trends in transaminase levels in children with infectious mononucleosis: an exploratory study.

Yulan Ma, 谢新宝, Yan Li, Fangfang Cheng et al.
PubMed
Viral-associated cancers and disorders
article

GBP5 as a potential marker for changing trends in transaminase levels in children with infectious mononucleosis: an exploratory study.

Yulan Ma, 谢新宝, Yan Li, Fangfang Cheng, Jiamei Tang, Jianmei Tian, Kun Wang, Yanyan Luo
article en

Abstract

OBJECTIVE: This study aims to explore whether GBP5 is associated with changing trends in transaminase levels in children with infectious mononucleosis (IM). METHODS: 100 children with IM were divided into the non-liver injury group (NLIG) and the liver injury group (LIG) according to liver function status. The expression level of GBP5 in peripheral blood mononuclear cells (PBMCs) from each group was measured using qPCR. All children with IM underwent liver function reexamination on day 14 after disease onset, leading to a further division into two groups based on these results: the non-progressive transaminase elevation group (NPTEG) and the progressive transaminase elevation group (PTEG). Clinical data and laboratory examination results from all enrolled children were collected for subsequent analysis. RESULTS: Compared with the NLIG, children in the LIG exhibited a higher GBP5 expression level (p < 0.05). Upon reexamination of liver function on day 14 of disease onset, some children showed progressive increases in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared to those at admission. In the PTEG, the expression levels of GBP5 were elevated (p < 0.05). ROC analysis suggested that GBP5 expression showed apparent discriminatory capacity for identifying the risk of progressive transaminase elevation in children with IM. The time to transaminase recovery below 2 × upper limit of normal (ULN) varied among children with IM-related liver injury. >50% achieved recovery within 30 days, with a maximum recovery time of 130 days. CONCLUSION: GBP5 demonstrated apparent predictive discrimination for changing trends in transaminase levels in children with IM, warranting further multivariable assessment and external validation.

PubMed
Soochow University (CN), Children's Hospital of Zhejiang University (CN), Children's Hospital of Fudan University (CN)
Viral-associated cancers and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon